Hexarelin studies: 245 papers with results
Page 2 of 5
- The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D · Clinical endocrinology · 1996
Non-randomized trial · 7 results
- Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects.
De Marinis L · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2000
Non-randomized trial · 3 results
- Does desensitization to hexarelin occur?
Rahim A · Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 1998
Non-randomized trial · 5 results
- The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients.
Murray RD · Clinical endocrinology · 2001
Non-randomized trial · 5 results
- Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen.
Guzzaloni G · Journal of endocrinological investigation · 1999
Non-randomized trial · 15 results
- Hexarelin, a novel GHRP-6 analog, counteracts the inhibitory effect of hydrocortisone on growth hormone secretion in acromegaly.
Giustina A · Endocrine research · 1995
Non-randomized trial · 2 results
- Intranasal administration of the GHRP hexarelin accelerates growth in short children.
Laron Z · Clinical endocrinology · 1995
Non-randomized trial · 7 results
- Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E · The Journal of clinical endocrinology and metabolism · 1999
Non-randomized trial · 4 results
- The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.
Loche S · The Journal of clinical endocrinology and metabolism · 1995
Non-randomized trial · 4 results
- Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children.
Klinger B · European journal of endocrinology · 1996
Non-randomized trial · 5 results
- Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.
Arvat E · Journal of endocrinological investigation · 1999
Non-randomized trial · 12 results
- Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
Arvat E · Journal of endocrinological investigation · 1997
Non-randomized trial · 10 results
- Lack of effect of hexarelin on TRH-induced TSH response in normal adult man.
Arosio M · Journal of endocrinological investigation · 1998
Non-randomized trial · 6 results
- Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH.
Arvat E · Peptides · 1997
Non-randomized trial · 16 results
- Modulation of growth hormone-releasing activity of hexarelin in man.
Arvat E · Neuroendocrinology · 1995
Non-randomized trial · 3 results
- Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E · Neuroendocrinology · 1998
Non-randomized trial · 9 results
- Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
Maccario M · Metabolism: clinical and experimental · 1995
Non-randomized trial · 3 results
- Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)
Laron Z · European journal of endocrinology · 1997
Non-randomized trial · 3 results
- Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.
Arvat E · Metabolism: clinical and experimental · 1997
Non-randomized trial · 8 results
- Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.
Arvat E · European journal of endocrinology · 2000
Non-randomized trial · 9 results
- Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.
Benso A · Journal of endocrinological investigation · 2003
Non-randomized trial · 7 results
- d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A · Neuropeptides · 2007
Non-randomized trial · 9 results
- Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans.
Broglio F · European journal of endocrinology · 2000
Non-randomized trial · 7 results
- Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
Maccario M · European journal of endocrinology · 2002
Non-randomized trial · 18 results
- Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F · Neuropeptides · 2008
Non-randomized trial · 8 results
- Age-related differences in growth hormone (GH) regulation during strenuous exercise.
de Vries WR · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2004
Non-randomized trial · 3 results
- The effects of dose, nutrition, and age on hexarelin-induced anterior pituitary hormone secretion in adult patients on maintenance hemodialysis.
Jenkins RC · The Journal of clinical endocrinology and metabolism · 1999
Non-randomized trial · 8 results
- Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men.
Cappa M · Journal of endocrinological investigation · 1995
Non-randomized trial · 4 results
- Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women.
Arvat E · Journal of endocrinological investigation · 1998
Non-randomized trial · 12 results
- Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.
Semenistaya E · Drug testing and analysis · 2015
Non-randomized trial · 9 results
- Growth hormone status during long-term hexarelin therapy.
Rahim A · The Journal of clinical endocrinology and metabolism · 1998
Non-randomized trial · 9 results
- Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
Broglio F · European journal of pharmacology · 2002
Non-randomized trial · 11 results
- The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin.
Rahim A · Clinical endocrinology · 1999
Non-randomized trial · 7 results
- Short term effect of intranasal administration of hexarelin--a synthetic growth hormone-releasing peptide. Preliminary communication.
Frenkel J · Journal of pediatric endocrinology & metabolism : JPEM · 1995
Non-randomized trial · 4 results
- Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Guzzaloni G · Minerva endocrinologica · 1998
Non-randomized trial · 9 results
- Growth hormone releasing peptides : physiological studies in man
Massoud AF · University College London (University of London) · 1997
Non-randomized trial · 5 results
- Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
Broglio F · Clinical endocrinology · 1999
Observational study · 2 results
- Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity.
Grottoli S · European journal of endocrinology · 1996
Observational study · 5 results
- Comparisons among old and new provocative tests of GH secretion in 178 normal adults.
Aimaretti G · European journal of endocrinology · 2000
Observational study · 6 results
- Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency.
Maheshwari HG · The Journal of clinical endocrinology and metabolism · 1999
Case report or series · 4 results
- Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors.
Arnaldi G · The Journal of clinical endocrinology and metabolism · 2003
Case report or series · 1 result
- Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers.
Frieboes RM · Psychoneuroendocrinology · 2004
Other design · 9 results
- Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.
Giustina A · The Journal of endocrinology · 1995
Other design · 1 result
- Structure-activity relationship for peptídic growth hormone secretagogues.
Ferro P · Drug testing and analysis · 2017
Other design · 7 results
- Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
Rossoni G · Journal of cardiovascular pharmacology · 1998
Animal study (in vivo) · rat · 8 results
- Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep.
Guillaume V · Endocrinology · 1994
Animal study (in vivo) · sheep · 3 results
- Sixteen weeks of hexarelin therapy in aged dogs: effects on the somatotropic axis, muscle morphology, and bone metabolism.
Cella SG · The journals of gerontology. Series A, Biological sciences and medical sciences · 1996
Animal study (in vivo) · dog · 7 results
- Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin.
Rigamonti AE · European journal of endocrinology · 1999
Animal study (in vivo) · dog · 3 results
- Growth hormone-independent cardioprotective effects of hexarelin in the rat.
Locatelli V · Endocrinology · 1999
Animal study (in vivo) · rat · 7 results
- The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.
Tivesten A · Endocrinology · 2000
Animal study (in vivo) · rat · 6 results